← Back to headlines
OmniAb Boosts 2026 Cash Outlook Following Eli Lilly Deal
OmniAb has revised its 2026 cash outlook upwards after finalizing a significant deal with pharmaceutical giant Eli Lilly.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
